New Therapy for Early-Stage Polycystic Kidney Disease: Combination of Difelikefalin and Tolvaptan

Authors

Juan Gao, LSU Health Sciences Center - New OrleansFollow
Kara Johnson, LSU Health Sciences Center - New OrleansFollow
Madison Grace Haggard, LSU Health Sciences Center - New OrleansFollow
Ian Bart Denys, LSU Health Sciences Center - New OrleansFollow
Mihran V. Naljayan, LSU Health Sciences Center - New OrleansFollow
Daniel R. Kapusta, LSU Health Sciences Center - New OrleansFollow

Document Type

Conference Proceeding

Publication Date

11-1-2023

Publication Title

Journal of the American Society of Nephrology

Abstract

Kidney Week 2023 Annual Meeting, November 2 - 5, 2023, Philadelphia, PA

Comments

Abstract Number: TH-PO411

Recommended Citation

Gao, Juan; Johnson, Kara; Haggard, Madison Grace; Denys, Ian Bart; Naljayan, Mihran V.; and Kapusta, Daniel R., "New Therapy for Early-Stage Polycystic Kidney Disease: Combination of Difelikefalin and Tolvaptan" (2023). School of Medicine Faculty Publications. 2686.
https://digitalscholar.lsuhsc.edu/som_facpubs/2686